日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Assessing circulating tumour DNA (ctDNA) as a prognostic biomarker in locally advanced rectal cancer: a systematic review and meta-analysis

评估循环肿瘤DNA(ctDNA)作为局部晚期直肠癌预后生物标志物的价值:系统评价和荟萃分析

O'Sullivan, Niall J; Temperley, Hugo C; Kyle, Eimear T; Sweeney, Kevin J; O'Neill, Maeve; Gilham, Charles; O'Sullivan, Jacintha; O'Kane, Grainne; Mehigan, Brian; O'Toole, Sharon; Larkin, John; Gallagher, David; McCormick, Paul; Kelly, Michael E

[Medical escape games: experimenting with a new teaching method]

【医疗逃脱游戏:尝试一种新的教学方法】

Larouche, Pauline; Sweeney, Kevin; Lajeunesse, Judith

Peptide conjugates with polyaromatic hydrocarbons can benefit the activity of catalytic RNAs

肽与多环芳烃的缀合物可以增强催化RNA的活性。

Sweeney, Kevin J; Le, Tommy; Jorge, Micaella Z; Schellinger, Joan G; Leman, Luke J; Müller, Ulrich F

Population PK/PD modeling of low-density lipoprotein cholesterol response in hypercholesterolemic participants following administration of bococizumab, a potent anti-PCSK9 monoclonal antibody

对高胆固醇血症患者给予强效抗PCSK9单克隆抗体bococizumab后低密度脂蛋白胆固醇反应进行群体药代动力学/药效学建模

Wang, Ellen Q; Kaila, Nitin; Plowchalk, David; Gibiansky, Leonid; Yunis, Carla; Sweeney, Kevin

Exposure to Epstein Barr virus and cognitive functioning in individuals with schizophrenia

接触EB病毒与精神分裂症患者的认知功能

Dickerson, Faith; Katsafanas, Emily; Origoni, Andrea; Squire, Amalia; Khushalani, Sunil; Newman, Theresa; Rowe, Kelly; Stallings, Cassie; Savage, Christina L G; Sweeney, Kevin; Nguyen, Tanya T; Breier, Alan; Goff, Donald; Ford, Glen; Jones-Brando, Lorraine; Yolken, Robert

End-to-end application of model-informed drug development for ertugliflozin, a novel sodium-glucose cotransporter 2 inhibitor

将基于模型的药物开发方法应用于新型钠-葡萄糖协同转运蛋白2抑制剂ertugliflozin的端到端开发

Fediuk, Daryl J; Nucci, Gianluca; Dawra, Vikas K; Callegari, Ernesto; Zhou, Susan; Musante, Cynthia J; Liang, Yali; Sweeney, Kevin; Sahasrabudhe, Vaishali

Population pharmacokinetics and exposure-response analyses of varenicline in adolescent smokers

伐尼克兰在青少年吸烟者中的群体药代动力学和暴露-反应分析

Fediuk, Daryl J; Sweeney, Kevin; Sahasrabudhe, Vaishali; McRae, Thomas; Byon, Wonkyung

Meta-Analysis of Noncompartmental Pharmacokinetic Parameters of Ertugliflozin to Evaluate Dose Proportionality and UGT1A9 Polymorphism Effect on Exposure.

对 Ertugliflozin 非房室药代动力学参数进行荟萃分析,以评估剂量比例性和 UGT1A9 多态性对暴露的影响

Marshall Jean-Claude, Liang Yali, Sahasrabudhe Vaishali, Tensfeldt Thomas, Fediuk Daryl J, Zhou Susan, Krishna Rajesh, Dawra Vikas Kumar, Wood Linda S, Sweeney Kevin

Predictions of Systemic, Intracellular, and Lung Concentrations of Azithromycin With Different Dosing Regimens Used in COVID-19 Clinical Trials

预测COVID-19临床试验中使用的不同给药方案下阿奇霉素的全身、细胞内和肺部浓度

Hughes, Jim H; Sweeney, Kevin; Ahadieh, Sima; Ouellet, Daniele

Population pharmacokinetic modeling of PF-06439535 (a bevacizumab biosimilar) and reference bevacizumab (Avastin(®)) in patients with advanced non-squamous non-small cell lung cancer

在晚期非鳞状非小细胞肺癌患者中,PF-06439535(贝伐单抗生物类似药)和参考贝伐单抗(阿瓦斯汀®)的群体药代动力学模型

Li, Cheryl S W; Sweeney, Kevin; Cronenberger, Carol